Sign in
CompletedNo phase

Survey Study on Barrett's Esophagus Screening

Key facts

Who runs it
University of Colorado, Denver
Where
Aurora, Dallas, and Philadelphia, United StatesSee the 7 sites
Trial code
Status
Completed
People taking part
725 people enrolled
Started
19 Feb 2020
Ended
1 Oct 2025
Type of study
Observational, 3 groups
Treatments tested
  • Primary Care Provider Survey
  • Gastroenterologist Survey
  • Patient Survey
Record updated
22 October 2025

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients identified by ICD-10 codes for GERD (K21.0 and K21.9) AND
  • Have had at least one outpatient clinic visit at a participating site
  • Provider must be a PCP and/or gastroenterologist AND
  • Must be at a participating site

Who cannot take part

  • Prior diagnosis of BE/EAC
  • Non-English speaking
  • Provider Eligibility Criteria

Other criteria

  • Patient Eligibility Criteria

Where in United States

  • Denver Health Medical CenterAurora, United States
  • University of Colorado HospitalAurora, United States
  • Parkland Health and Hospital SystemDallas, United States
  • University of Texas Southwestern Medical CenterDallas, United States
  • Hospital of the University of PennsylvaniaPhiladelphia, United States
  • Pennsylvania HospitalPhiladelphia, United States
  • Pennsylvania Presbyterian HospitalPhiladelphia, United States

About the trial

What the trial wants to find out

The goal of this study is to optimize Barrett's Esophagus (BE) screening to reduce the incidence, morbidity, and mortality of Esophageal Adenocarcinoma (EAC).

The 3 groups in the trial

  • Primary Care Providers

    400 eligible primary care providers (PCPs) will be recruited across the 7 participating sites to complete an anonymous survey. The survey will be distributed to eligible PCPs by the study site research coordinator via anonymous REDCap internet survey with 2 additional automated electronic reminders. There will also be opportunities for providers to complete a paper survey at PCP clinic meetings which will be collected by only the site research coordinator to maintain response anonymity.

    Treatment: Primary Care Provider Survey

  • Gastroenterologists

    100 eligible gastroenterologists (GIs) will be recruited across the 7 participating sites to complete an anonymous survey. The survey will be distributed to eligible GIs by the study site research coordinator via anonymous REDCap internet survey with 2 additional automated electronic reminders. There will also be opportunities for GIs to complete a paper survey at provider clinic meetings which will be collected by only the site research coordinator to maintain response anonymity.

    Treatment: Gastroenterologist Survey

  • Patients

    500 eligible patients will be recruited across the 7 participating sites to complete a survey. The survey will be distributed to eligible patients at the time of a clinic appointment, via telephone, or via a REDCap internet survey that will allow for 2 additional electronic phone call reminders and 1 email reminder.

    Treatment: Patient Survey

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Study of Compliance, Practice Patterns, and Barriers REgarding Established National Screening Programs for Barrett's Esophagus: SCREEN-BE
Publications
Record updated
22 October 2025